A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.

GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among Immunocompromised Patients ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb ...

Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.

ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, ...

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...

During the trial, none of the participants needed blood transfusions, and 92.7% of them reached Hb levels of at least 12g/dL.

will be presented at the European Hematology Association (EHA) 2025 Hybrid Congress, taking place June 12-15, 2025, in Milan, Italy and online. The presentation will highlight initial results from ...

Following the 18th European Hematology Association Congress, pharmaphorum's Hannah Blake spoke with hematology expert, Dr Moshe Talpaz, to find out more about the research and development ...

Nurix Therapeutics (NRIX) stock falls as the company posts new early-stage trial data for its lead asset bexobrutideg ...